BiotechTubeBiotechTube
Home/Passage Bio/William Chou
WC

William Chou

Chief Executive Officer

Passage Bio

Therapeutic Areas

NeurologyNeurodegenerative DiseasesRare DiseasesGenetic Disorders

Passage Bio Pipeline

DrugIndicationPhase
PBFT02Frontotemporal Dementia (FTD) with progranulin (GRN) gene mutationsPhase 1/2
PBGM01Infantile GM1 GangliosidosisPhase 1/2

Leadership Team at Passage Bio

BG
Bruce Goldsmith
President and Chief Executive Officer
AF
Alex Fotopoulos
Chief Financial Officer
JM
James M. Wilson
Co-Founder, Chief Scientific Advisor
SS
Stephen Squinto
Co-Founder and former Interim CEO
TY
Tachi Yamada
Co-Founder and former Chief Medical Officer
KH
Katherine High
Board Member
View full Passage Bio profile